SEASUN BIOMATERIALS

Dejeon, 
Korea (South)
http://www.seasunbio.com
  • Booth: 2171

Booth Profile

We provide easy-to-use molecular/genetic diagnostic platforms with high sensitivity and specificity focused on sectors of Obstetrics-Gynaecology and Oncology using our original patented diagnostic technologies You are welcomed to visit us to look over our products aimed at detection of Congenital and Infectious hearing loss, Fetal chromosomal abnormalities (Prenatal test), Microsatellite Instability, Infections of Helicobacter pylori (its antibiotic resistance) and much more.


 Press Releases

  • Seasun Biomaterials launched prenatal screening kit for Down, Edward, Patau syndrome utilizing real time PCR. This test is based on PatioTM technology, which detects chromosomal abnormality of fetal DNA that exists in maternal amniotic fluid with high sensitivity and accuracy. It acquired IVD class 3 certification from Ministry of Food and Drug Safety (MFDS) in December, 2018. It needs 3 hours to conduct the test, and 23 samples can be analyzed simultaneously. Seasun Biomaterials also launched non-invasive prenatal screening service using circulating cell-free fetal DNA in maternal plasma.

  • U-TOP™ MSI Plus Detection Kit is a real time PCR-based product, which detects microsatellite instability (MSI) in circulating tumor DNA (ctDNA). This technology has been proven to be able to amplify unstable microsatellite repeat sequence in ctDNA more efficiently and detect them by 0.05%. The blood-based test with “U-TOPTM MSI Plus” is non-invasive, rapid, and precise. It can be especially used to screen patients who have difficulty in biopsy or who have metastatic cancer and want to monitor the cancer development

    The test results are reported after analyzing 5 MSI markers (Quasi mononucleotide markers), and MSI status gets to be classified into MSI-H, MSI-L, or MSS (MSI stable). The running time is 3.5 hours excluding DNA prep, and results are automatically reported with MeltingArray™ Analyzer.

    Seasun Biomaterials has launched the first line of MSI detection kits targeting tumor tissue in 2017, the first MSI detection product is based on real-time PCR approved by KFDA and CE-marked.


 Additional Info

Included in the Export Interest Directory?
Yes
Business Needs:
Direct Sales, Distributor/Agent/Representative, Joint Ventures
Products to be exported:
Real time PCR based detection kits 1. Microsatellite instability detection kit 2. H. pylori infection/antibiotic resistance determination kit 3. Prenatal screening kit for chromosomal abnormalities using amniocentesis 4. NIPT service using maternal blood 5. Detection kit of inherited hearing loss related mutations 6. CMV Detection/Quantification kit 
Countries of Interest:
1. All Countries listed below